Kymera Therapeutics, Inc.
KYMR
Clasificación en acciones
#2280
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Precio por acción
$107.81
Capitalización bursátil
$8.87B
Cambio (1 día)
2.89%
Cambio (1 año)
80.19%
País
US
Comercio Kymera Therapeutics, Inc. (KYMR)
Categoría
Healthcare
EPS de Kymera Therapeutics, Inc. (KYMR)
EPS a fecha de June 2026 TTM: $-3.25
Según los últimos informes financieros y el precio de las acciones de Kymera Therapeutics, Inc., el EPS actual de la empresa (TTM) es $-3.25. Al final del año 2023, la empresa tenía un EPS de $-2.52 una disminución en comparación con al EPS de 2022, que fue de $-2.87.
Historial de EPS de Kymera Therapeutics, Inc. desde 2018 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2026 (TTM) | $-3.25 | 9.06% |
| 2024 | $-2.98 | 18.25% |
| 2023 | $-2.52 | -12.20% |
| 2022 | $-2.87 | 37.32% |
| 2021 | $-2.09 | 111.11% |
| 2020 | $-0.99 | 6.45% |
| 2019 | $-0.93 | 93.75% |
| 2018 | $-0.48 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| $17.32 | -632.92% |
US
|
|
| $-7.98 | 145.54% |
US
|
|
| $-5.29 | 62.77% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -953.54% |
NL
|
